FDA Enforcement Class II Ongoing

Medtronic, REF: MMT-7008D, Enlite Glucose Sensor for the following packaging: ENLITE AUS 1 PRESS 1PK; GTIN: 00763000252045 Product Usage: intended for use with Medtronic Diabetes (Medtronic) glucose sensing systems to continuously monitor glucose levels in persons with diabetes. *Product not distributed within US.

Recall: Z-1618-2021 · Reported May 26, 2021

Enforcement

Recall Number
Z-1618-2021
Event ID
87476
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Medtronic Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Report Date
May 26, 2021
Initiation Date
February 26, 2021
Classification Date
May 17, 2021
Address
18000 Devonshire St, N/A, Northridge, CA, 91325-1219, United States

Description

Medtronic, REF: MMT-7008D, Enlite Glucose Sensor for the following packaging: ENLITE AUS 1 PRESS 1PK; GTIN: 00763000252045 Product Usage: intended for use with Medtronic Diabetes (Medtronic) glucose sensing systems to continuously monitor glucose levels in persons with diabetes. *Product not distributed within US.

Reason

Use of the continuous glucose monitoring system while actively taking hydroxyurea, an anti-neoplastic drug could result in inaccurate elevated sensor glucose readings.

Code Info

All Lot numbers within active shelf life

Distribution

Worldwide distribution.

Quantity

207 units